Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. [electronic resource]
Producer: 20000914Description: 2972-80 p. digitalISSN:- 0732-183X
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Renal Cell -- drug therapy
- Disease-Free Survival
- Female
- Humans
- Injections, Subcutaneous
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Isotretinoin -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Models, Statistical
- Multivariate Analysis
- Quality of Life
- Recombinant Proteins
- Statistics, Nonparametric
- Surveys and Questionnaires
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.